Sort
17,054 grants matching “genome editing”
Systematic characterization of trans regulation of A-to-I RNA editing in neurons
$454,422Jin Billy Li · Stanford University · R01 · FY2019 · MH
High-throughput precision genome editing to characterize natural genetic variants
$454,393Hunter B Fraser · Stanford University · R01 · FY2022 · GM
High-throughput precision genome editing to characterize natural genetic variants
$454,393Hunter B Fraser · Stanford University · R01 · FY2021 · GM
Ocular Gene Therapy
$454,334Tiansen Li · National Eye Institute · ZIA · FY2020 · EY
Targeting Promoter G-quadruplexes with CRISPR-dCas9 for Transcription Regulation
$454,327Hamza Balci · Kent State University · R15 · FY2022 · GM
Predicting causal non-coding variants in a founder population
$454,272Stephen Montgomery · Stanford University · R01 · FY2017 · HG
Predicting causal non-coding variants in a founder population
$454,272Stephen Montgomery · Stanford University · R01 · FY2016 · HG
C9ORF72 in Motor System Biology and ALS
$454,237Kevin C Eggan · Harvard University · R01 · FY2017 · NS
Developing newly combined therapeutic strategies for mature B cell lymphoma
$454,144Jing Hong Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Systematic characterization of trans regulation of A-to-I RNA editing in neurons
$454,121Jin Billy Li · Stanford University · R01 · FY2020 · MH
Enabling tools for protists pathogen glycobiology
$453,932Christopher M. West · University Of Georgia · R21 · FY2016 · AI
Harnessing Broad-Specificity Phage Recombinases for Universal Bacterial Editing platforms
$453,900Andrew Varble · University Of Rochester · DP2 · FY2024 · AI
Harnessing Broad-Specificity Phage Recombinases for Universal Bacterial Editing platforms
$453,900Andrew Varble · University Of Rochester · DP2 · FY2025 · AI
Systematic characterization of trans regulation of A-to-I RNA editing in neurons
$453,815Jin Billy Li · Stanford University · R01 · FY2021 · MH
Project 4: Therapeutic Gene Editing for Rett Syndrome
$453,755Cathleen M Lutz · Jackson Laboratory · U19 · FY2025 · NS
A novel bioengineered model of iPSC-derived neural tissue to study of Alzheimer's disease
$453,750Giuseppina Tesco · Tufts University Boston · R21 · FY2020 · AG
Innovative Approaches to Treating Alport Syndrome
$453,731Jeffrey H Miner · Washington University · R01 · FY2021 · DK
Innovative Approaches to Treating Alport Syndrome
$453,731Jeffrey H Miner · Washington University · R01 · FY2022 · DK
Role of TET dioxygenase associated immune mechanisms in cardiac injury and repair
$453,498Yun Huang · Texas A&M University Health Science Ctr · R01 · FY2019 · HL
Genetics of conotruncal defects and associated neurodevelopmental outcomes
$453,446Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · UM1 · FY2017 · HL
Genetics of conotruncal defects and associated neurodevelopmental outcomes
$453,446Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · UM1 · FY2018 · HL
Genetics of conotruncal defects and associated neurodevelopmental outcomes
$453,446Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · UM1 · FY2019 · HL
Genetics of conotruncal defects and associated neurodevelopmental outcomes
$453,446Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · UM1 · FY2016 · HL
Genetics of conotruncal defects and associated neurodevelopmental outcomes
$453,446Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · UM1 · FY2015 · HL
Regulation of RNA editing in two life cycle stages of Trypanosoma brucei
$453,429Jorge Cruz-Reyes · Texas A&M Agrilife Research · R01 · FY2025 · AI